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Background. Despite extensive use, different aspects of the pharmacological action of
epidural fentanyl have not been clari®ed. We applied a multi-modal sensory test procedure to
investigate the effect of epidural fentanyl on segmental spread, temporal summation (as a
measure for short-lasting central hyperexcitability) and muscle pain.
Methods. Thirty patients received either placebo, 50 or 100 mg single dose of fentanyl
epidurally (L2±3), in a randomized, double-blind fashion. Heat pain tolerance thresholds at
eight dermatomes from S1 to ®fth cranial nerve (assessment of segmental spread), pain
threshold to transcutaneous repeated electrical stimulation of the sural nerve (assessment of
temporal summation) and pain intensity after injection of hypertonic saline into the tibialis
anterior muscle (assessment of muscle pain) were recorded.
Results. Fentanyl 100 mg, but not 50 mg, produced analgesia to heat stimulation only at L2.
Surprisingly, no effect at S1 was detected. Both fentanyl doses signi®cantly increased temporal
summation threshold and decreased muscle pain intensity.
Conclusions. The ®ndings suggest that a single lumbar epidural dose of fentanyl should be
injected at the spinal interspace corresponding to the dermatomal site of pain. Increased effect
on L2 compared with S1 suggests that drug effect on spinal nerve roots and binding to opioid
receptors on the dorsal root ganglia may be more important than traditionally believed for
the segmental effect of epidurally injected fentanyl. Epidural fentanyl increases temporal
summation threshold and could therefore contribute to prevention and treatment of central
hypersensitivity states. I.M. injection of hypertonic saline is a sensitive technique for detecting
the analgesic action of epidural opioids.
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Epidural fentanyl is largely used to provide analgesia for
acute pain1 2 and to enhance the quality of epidural block for
intraoperative analgesia.3 Despite extensive use, several
aspects of its action remain unknown.
Low doses of epidural fentanyl administered at a lumbar
level produce a greater analgesic effect at the foot than at the
®nger,4 which suggests that epidural fentanyl has not only a
systemic, but also a segmental effect. Another investigation
comparing epidural with i.v. administration came to the
same conclusion.5 However, the effect of fentanyl at
different dermatomes has not been quanti®ed. Therefore,
it is not known at which dermatomes analgesia is most
profound. This information is important for de®ning the site
of injection to achieve a spinal segmental effect.
Repeated nociceptive stimulation produces sensitization
of spinal cord neurones.6 As a result, innocuous stimuli can
be perceived as painful (central hypersensitivity). Temporal
summation occurs when repeated stimuli of constant
intensity evoke an increase in perception.7 Short-lasting
neuronal hyperexcitability induced by repeated stimulation
probably accounts for this phenomenon.7 Facilitated tem-
poral summation has been found in various pain
syndromes8±10 and may partly explain exaggerated pain in
the presence of minimal nociceptive input. The effect of
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epidural opioids on temporal summation is still to be
investigated.
So far, sensory assessment of epidural opioid analgesia
has been performed using cutaneous stimulation. No data
are available regarding the effect of epidural opioids on
experimentally induced muscle pain. Given the importance
of deep pain in clinical conditions, a wider use of deep pain
models is desirable.11 For this purpose it is important to
know whether muscle pain models are sensitive for
detecting the analgesic effect of epidural opioids.
This study applies a multi-modal test procedure11 to
clarify three aspects of the pharmacological actions of
epidural fentanyl: segmental spread, modulation of tem-
poral summation and muscle pain.
Methods
Patients
The study was approved by the ethics committee of the
University of Bern. Written informed consent was obtained
from all patients. The sample size was calculated based on
heat tolerance threshold measurements. We arbitrarily
chose to detect a minimal temperature difference of 2.5°C.
Setting a=0.05 and SD=1.5°C (observed previously21), 10
subjects per group need to be analysed to detect a difference
of 2.5°C with a power of b=0.9. To achieve this sample size
we had to enrol 34 ASA class I±II patients, undergoing
epidural anaesthesia for elective extracorporeal shock wave
lithotripsy (ESWL). Exclusion criteria were: age less than
18 or more than 70 yr, a history of alcohol abuse or intake of
psychotropic drugs, intake of opioids or non-steroidal anti-
in¯ammatory drugs in the past week, intake of other
analgesics or sedatives in the last 24 h, coagulation
abnormalities, a history of coronary artery disease, preg-
nancy, fever, musculoskeletal pain conditions and any other
contraindication to epidural block.
The investigation was conducted in a randomized,
double-blind, placebo-controlled fashion. Randomization
was strati®ed using the minimization method12 according to
age (<45 or >45 yr), body weight (<75 or >75 kg) and body
height (<170 or >170 cm) and was performed by drawing
lots.
Anaesthetic procedure
The patients fasted for at least 6 h and did not receive
any premedication on the day of investigation.
Electrocardiogram, non-invasive arterial pressure (one
measurement every 10 min) and haemoglobin oxygen
saturation using pulse oximetry (SpO2) were monitored
with a Hellige Servomed monitor (Hellige AG, Freiburg,
Germany).
All epidural punctures were performed in the sitting
position, with an 18G Tuohy-needle, using the midline
approach at the L2±3 interspace. The L4 spinous process,
palpated at the level of the iliac crest, was used as a
reference to identify the L2±3 interspace.13 The epidural
space was identi®ed by loss of resistance, injecting no more
than 3 ml of saline 0.9%. A multi-pore catheter was inserted
5 cm cephalad in the epidural space. Then the baseline
measurements (see below) were performed.
At the end of baseline recordings, patients received in a
randomized fashion an epidural injection of either fentanyl
50 or 100 mg, or saline 0.9%. Fentanyl was diluted in saline
0.9%, and the total volume of the three solutions was 15 ml.
The solutions were prepared by a person who was not
involved with the measurements. The solution to be tested
was injected over 10 s via the epidural ®lter and ¯ushed with
1 ml of saline.
At the end of the experiment, 3±5 ml increments of
lidocaine 2% with epinephrine 5 mg ml±1 were administered
epidurally until a bilateral cranial spread up to T4 as
assessed by cold stimulation was reached. Thereafter, the
patient was transported to the operating room for ESWL.
Testing procedure
All the tests were performed on the right side. In all
threshold assessments, the mean of three measurements was
used for data analysis.
Heat pain tolerance thresholds (assessment of segmental
effect)
Heat stimulation was performed on the following derma-
tomes: S1 (lateral aspect of the foot, 3 cm distal to the lateral
malleolus), L4 (5 cm above the middle of the patella, on a
line between this point and the anterior superior iliac spine),
L2 (on the same line as for L4, 10 cm under the superior
iliac spine), T12 (4 cm above the pubic symphysis, 5 cm
lateral to the median line), T8 (on a horizontal line passing
through the middle between the xyphoid and the umbilicus,
5 cm lateral to the median line), T4 (on a horizontal line
passing through the mammilla, 5 cm lateral to the median
line), C8 (on the lateral aspect of the hypothenar) and ®fth
cranial nerve (2 cm above the middle of the eyebrow). Heat
pain tolerance threshold was determined with a computer-
ized version of the Thermotest (Somedic AB, Stockholm,
Sweden). The hand-held thermode consists of Peletier
elements (25350 mm) and was applied in full contact to the
skin. For heat pain tolerance thresholds, a starting tempera-
ture of 30°C (0.2) and a 2.0°C s±1 rate of change (heating
and return to baseline) was used. The patient was instructed
to press a button when he could no more tolerate the evoked
pain. This temperature was automatically recorded, and the
thermode cooled to the baseline temperature. To avoid skin
damage a cut-off limit of 52°C was set. If patients did not
press the button at 52°C, this value was considered as pain
tolerance threshold.
Eichenberger et al.
468
Repeated electrical stimulation (assessment of temporal
summation)
After the skin had been degreased with alcohol, bipolar
surface Ag±AgCl electrodes were placed just distal to the
lateral malleolus for transcutaneous electrical stimulation
(sural nerve stimulation, corresponding to root S1).
Stimulation was performed with a computer-controlled
constant current stimulator (NOXITEST, Aalborg,
Denmark). A 25-ms train-of-®ve 1-ms square-wave impulse
(perceived as a single stimulus) was used. This stimulus
burst was repeated ®ve times with a frequency of 2 Hz
(i.e. every 0.5 s).7 The current intensity was increased from
1 mA in steps of 0.5 mA, until a subjective pain sensation
was evoked. Then the stimulation intensity was reduced and
increasing it again using smaller steps the temporal
summation threshold was found. Temporal summation
pain threshold was de®ned as the current intensity that
evoked an increase in perception during the ®ve stimuli, so
that the last one to two stimuli were perceived as painful.
When pain was evoked at the ®rst of the ®ve impulses, in the
absence of increase in perception during the ®ve stimuli, this
point was used for data analysis.
Intramuscular injection of hypertonic saline (assessment of
muscle pain)
Muscle pain was induced by injection of hypertonic saline.
A Harvard 22 infusion Pump (Harvard Apparatus,
Edenbridge, Kent, UK) was connected through an extension
tube to a stainless disposable needle (27G, 40 mm).14 The
needle was introduced in the tibialis anterior muscle, 14 cm
distal from the caudal end of the patella, 2 cm lateral to the
anterior edge of the tibia, and 20 mm in depth (correspond-
ing to myotomes L4 and L5). Hypertonic NaCl 5% 0.5 ml
was administered over 20 s. During 7 min patients rated the
pain intensity continuously on a electronic 10-cm visual
analogue scale (VAS), where 0 cm indicated `no pain' and
10 cm `the worst imaginable pain'. Data were saved on
computer every 5 s. The area below the curve (VASarea)
over the recording period was calculated. The subjects were
asked to draw the site and extension of local pain (i.e. pain at
the site of i.m. injection) and referred pain (i.e. pain referred
to an area at distance from the site of injection) on an
anatomical map. The circumference was digitized
(ACECAD D9000 + digitizer, Taiwan), and the area
calculated (Sigma-Scan, Jandel Scienti®c, Canada).14
Time schedule
After insertion of the epidural catheter, all the test
modalities, except i.m. injection of saline (in order not to
cause irritation of the muscle before the measurements),
were performed for training. Then baseline measurements
were recorded for all tests including muscle pain.
End of injection of the epidural solution was considered
as time zero. The reported time below represents the start of
the test series. The following test series were performed:
(1) heat pain tolerance thresholds (dermatomes S1, L2, and
®fth cranial nerve) at 6 and 14 min;
(2) heat pain tolerance thresholds at all tested dermatomes
(S1, L2, L4, T12, T8, T4, C8, and ®fth cranial nerve) at
22 min;
(3) electrical stimulation at 34 min;
(4) heat pain tolerance thresholds (dermatomes S1, L2, and
®fth cranial nerve) at 40 min;
(5) i.m. injection of hypertonic saline at 47 min;
(6) heat pain tolerance thresholds (dermatomes S1, L2, and
®fth cranial nerve) at 56 min.
Within each test series, the assessments were made in a
randomized order and the exact time difference to time zero
was measured.
Statistical analysis
Differences in age, weight, height, amount of lidocaine
injected after the experiment among the three treatment
groups were analysed by one way analysis of variance
(ANOVA, for normally distributed data) or Kruskal±Wallis
one way ANOVA on ranks (for not normally distributed data).
Differences in gender distribution were analysed by c2 test.
To analyse data concerning sensory tests, the differences
(assessment after medication) ± (assessment before medi-
cation) were used.
For heat pain tolerance thresholds, data were ®rst
analysed graphically. Because the largest differences
among groups and among dermatomes were observed at
14 min (Fig. 1), statistical analyses were performed at this
time. To ®nd out at which dermatome (S1, L2, or ®fth
cranial nerve) and after which treatment (placebo, fentanyl
50 or 100 mg) fentanyl produced signi®cant analgesia, a two
way repeated measures ANOVA (with dermatome as repeated
factor) was performed. The relatively low number of
observations did not allow a comprehensive statistical
analysis of all data for all times and dermatomes.
To analyse temporal summation thresholds, VASarea, and
area of local pain after i.m. hypertonic saline injection, one
way ANOVA (for normally distributed data) or
Kruskal±Wallis one way ANOVA on ranks (for not normally
distributed data) were used.
In all analyses the Tukey test was used for multiple
comparison. A P<0.05 was considered signi®cant. The
software used was SigmaStat for Windows, version 2.03
(Jandel Corporation, San Rafael, CA, USA).
Results
Except pruritus in four patients, no side effects were
observed. Of the 34 patients enrolled, four were not
included in the analyses: unilateral spread of the local
anaesthetic after the end of the measurements (n=2),
intravascular location of the epidural catheter (n=1), occur-
rence of back pain during the investigation that could
possibly interfere with the measurements (n=1). Therefore,
the analyses were performed on 30 patients, 10 patients in
each group.
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Patient characteristics and lidocaine dose to achieve a
cranial spread up to T4 are shown in Table 1. We found no
signi®cant differences among the three groups.
Heat pain tolerance thresholds (assessment of
segmental effect)
Fentanyl 100 mg, but not 50 mg, produced analgesia to heat
stimulation only at L2 (P<0.05). Surprisingly, no effect at
S1 was detected. The time course of heat pain tolerance
thresholds for the dermatomes S1, L2 and ®fth cranial nerve
are shown in Figure 1. Figure 2 shows heat pain tolerance
thresholds for all dermatomes 22 min after epidural
injection of the different solutions.
Repeated electrical stimulation (assessment of
temporal summation)
The results are shown in Table 2. We found statistically
signi®cant increases in temporal summation thresholds
between the placebo group and both fentanyl 50 and 100
mg groups, respectively. No statistically signi®cant differ-
ences between the two fentanyl groups were found.
I.m. injection of hypertonic saline (assessment of
muscle pain)
The results are shown in Table 2. After i.m. injection of
hypertonic saline there was a statistically signi®cant
decrease in VASarea between placebo and both treatment
groups. No statistically signi®cant differences between the
two fentanyl groups were found.
The calculated means (SD) of the differences of the local
pain areas drawn by the patients (area after minus area
before epidural injection) in arbitrary units were: placebo
group 0.75 (1.54), fentanyl 50 mg group ±0.38 (0.70) and
fentanyl 100 mg group ±0.07 (0.57). No statistically
signi®cant differences among groups were found. Because
only one subject in the placebo group, two subjects in the
fentanyl 50 mg group and one subject in the fentanyl 100 mg
group reported referred pain, we did not calculate these
areas.
Discussion
Assessment of segmental effect
Using the heat model, we found a statistically signi®cant
effect of epidural fentanyl 100 mg, but not 50 mg, on
dermatome L2 (segment of injection). Neither S1 nor ®fth
cranial nerve were affected. This ®nding was surprising and
challenges the traditional belief that the spinal action of
epidural fentanyl is the result of penetration through the
dura and diffusion from cerebrospinal ¯uid to dorsal horn
neurones. If this was the case, the effect on S1 had to be at
least as profound as the effect on L2, since the distance
between site of dura penetration at L2±3 and S1 dorsal horn
neurones is shorter than the distance to the L2 dorsal horn
neurones. A possible explanation for the better effect of
epidural fentanyl on L2 than on S1 dermatome could be a
direct drug effect on the spinal nerve roots and binding to
opioid receptors of dorsal-root ganglia.
Fentanyl was shown to block in vitro rabbit vagus nerve
conduction, which suggests a local anaesthetic-type ac-
tion.15 16 Arendt-Nielsen and colleagues found hypoalgesia
to laser pain 15 min after perineural ulnar injection of 4 mg
of morphine in humans.17 In the same study lidocaine and
Fig 1 Time course of heat pain tolerance threshold (differences to
baseline measurements) over a time period of 60 min after epidural
injection of saline, fentanyl 50 and 100 mg. Means and SD are plotted.
*P<0.05 (two way repeated measurements ANOVA). No difference
between fentanyl 50 mg and placebo was found (not tested).
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morphine increased the latency of pain-evoked brain
potentials, which may have been the result of the above
effect on nerve conduction. An anatomical study18 showed a
smaller cross-section area of the thoracic and high lumbar
nerve roots compared with the low lumber and sacral roots.
This may lead to a better local anaesthetic type action of
fentanyl on the smaller root L2 compared with S1.
Animal studies have shown the existence of opioid
binding sites in spinal roots.19 Therefore, a direct binding of
opioids to receptors in the dorsal-root ganglia may play a
role in the antinociceptive effects of opioids.20 The larger
anatomical distance from the epidural site of injection to the
dorsal-root ganglion of S1 compared with L2 may be an
additional explanation for the better antinociceptive effect
of fentanyl on L2 in our study.
Another reason for the limited local action of fentanyl
measured with the heat pain model could be the relatively
poor rostral spread via the cerebrospinal ¯uid and the
trapping of fentanyl in the epidural fat.21
Lack of effect on heat pain threshold measured at S1 and
®fth cranial nerve in our study does not mean that epidural
fentanyl has no effect on this area. In fact, we could detect
an effect on L4/L5 and S1 by the muscle pain and the
temporal summation model, respectively. Furthermore, our
data are not in contrast with the convincing evidence that
epidural fentanyl has also or primarily a systemic analgesic
effect via vascular absorption from the epidural space.21
Recently, a study by our group showed that heat pain is not
the optimal model for detecting the analgesic effect of i.v.
alfentanil,22 although heat pain tolerance thresholds are
more sensitive to detect opioids effects than heat pain
detection thresholds.23 24 Thus, we may have measured the
analgesic action of fentanyl on heat pain only at the site of
maximum effect, for example L2. The muscle pain and the
temporal summation models may be more sensitive than
heat pain to detect opioid induced analgesia. This could also
explain the shorter duration of action compared with
previous investigations25 26 and the lack of effect of the 50
mg dose on heat pain in our study.
Our results differ from those obtained in previous
investigations on epidural morphine. Using laser stimula-
tion, Arendt-Nielsen and colleagues27 found a longer effect
of epidural morphine on S1 than on more cranial
dermatomes after injection at L2±3. Angst and colleagues28
found lumbar epidural morphine attenuated heat pain up to
trigeminal level. These ®ndings are likely to be explained by
the hydrophilicity and spinal cord availability of morphine
compared with fentanyl.21 These characteristics determine a
higher rostral spread in the cerebrospinal ¯uid and possibly
deeper spinal analgesia by morphine than by fentanyl. This
may make heat pain models more sensitive for epidural
morphine than for epidural fentanyl effects.
Assessment of temporal summation
Neither the temporal summation nor the muscle pain
assessments were designed to demonstrate segmental
effects of epidural fentanyl. Therefore, the study does not
provide information on the extent to which systemic effects
contribute to analgesia detected by these sensory modalities.
In the present study, repeated electrical stimulation was
used to investigate the central integrative mechanism
(temporal summation). In previous studies, temporal sum-
mation was attenuated, but not completely inhibited, by
Table 1 Patient characteristics and lidocaine dose given after the experiment
to achieve T4. Values are mean (SD or range). No statistically signi®cant
differences among groups were found in any variable
Saline Fentanyl 50 mg Fentanyl 100 mg
Sex (m/f) 8/2 9/1 7/3
Age (yr) 49.7 (25±68) 49.2 (24±70) 46.7 (33±68)
Weight (kg) 72.6 (12.1) 85.9 (14.5) 76.6 (14.5)
Height (cm) 170.0 (9.2) 176.0 (6.1) 171.4 (9.1)
Lidocaine 2% (ml) 20.7 (6.1) 20.8 (6.1) 20.9 (5.9)
Fig 2 Heat pain tolerance threshold measurements (differences to
baseline measurements) in all studied dermatomes 22 min after epidural
injection. Means and SD are plotted. The data were not analysed for
statistical signi®cance.
Table 2 Repeated electrical stimulation and i.m. injection of hypertonic
saline. Pain thresholds on repeated transcutaneous electrical stimulation
(temporal summation) 34 min after epidural injection and continuous VAS
rating after i.m. hypertonic saline injection 47 min after epidural injection.
Values are differences from baseline measurements, mean (SD). *P<0.05 vs
fentanyl 50 and 100 mg
Saline Fentanyl
50 mg
Fentanyl
100 mg
Electrical stimulation (mA) 0.17 (0.35)* 0.95 (0.91) 0.96 (0.59)
Hypertonic saline VASarea (cm
2) 531 (990)* ±390 (166) ±315 (528)
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epidural local anaesthetics29 and epidural clonidine.30
Conversely, intrathecal bupivacaine completely blocked
temporal summation.31 In the present study, epidural
fentanyl increased temporal summation threshold, indicat-
ing attenuation rather than complete inhibition of temporal
summation (Table 2). As mentioned above, we cannot rule
out that we measured primarily a systemic effect of fentanyl
with this test.
Temporal summation seems to be mediated by the
N-methyl-D-aspartate (NMDA) receptor.32 Opioids do not
act directly on the NMDA receptor, but may attenuate
temporal summation unspeci®cally by reducing the
nociceptive input to the dorsal horn neurones. It is
conceivable that temporal summation shares common
features with central hyperexitability involved in clinical
pain.33 Therefore, the temporal summation model may be
more useful than short-lasting transient stimuli for predict-
ing the response to analgesics in the clinical environment.
Our result may explain why epidural opioids alone may
provide only potential prevention of central hypersensitivity
states.34
Assessment of muscle pain
This is the ®rst study on regional analgesia that includes an
experimental muscle pain model. This is an important
development in pain research, given the relevance of deep
pain in clinical conditions.
Our data show that i.m. injection of hypertonic saline
detects the analgesic effect of epidural fentanyl (Table 2). In
a previous study, we found that i.v. remifentanil inhibits
pain after i.m. electrical stimulation more profoundly than
pain after cutaneous electrical stimulation.35 Thus, includ-
ing a muscle pain model in the experimental test of new
drugs would probably allow a better evaluation of drug
action than procedures including only skin stimulation. It
was not possible to show an effect of fentanyl on the area of
pain drawn on the anatomical map induced by hypertonic
saline although the pain intensity (VASarea) was signi®-
cantly decreased in the fentanyl groups compared with
placebo. The diffuse localization of muscle pain may result
in high inter-individual variations causing the non-signi®-
cant effects on the drawn pain area.
Also, concerning VASarea the muscle pain model was
associated with high inter-individual variability, as shown
by the high standard deviations in all groups. This may be
the result of the dif®culty of some patients in adjusting
continuously the pain intensity on the VAS. Some patients
may lose concentration during the procedure and therefore
forget to adapt the VAS scale to the real pain intensity.
Furthermore, small changes in the needle position during
the experiment may lead to stimulation of different muscle
locations with possible consequent change in intensity of
nociceptive stimulation. Despite its usefulness, this model
still needs to be improved.
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